Linked Data API

Show Search Form

Search Results

1054660
registered interest false more like this
date less than 2019-02-04more like thismore than 2019-02-04
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cerliponase Alfa more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will hold meetings with families of children with ceroid lipofuscinosis type 2 disease on the availability of Brineura on the NHS. more like this
tabling member constituency Leeds North West remove filter
tabling member printed
Alex Sobel more like this
uin 216384 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-02-12more like thismore than 2019-02-12
answer text <p>The Department has no plans currently. The National Institute for Health and Care Excellence is currently developing guidance on Brineura (Cerliponase alfa) for treating neuronal ceroid lipofuscinosis type 2 under the highly specialised technology programme. Further information can be found at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/indevelopment/gid-hst10008" target="_blank">https://www.nice.org.uk/guidance/indevelopment/gid-hst10008</a></p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-02-12T15:49:07.43Zmore like thismore than 2019-02-12T15:49:07.43Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4658
label Biography information for Alex Sobel more like this